FDA recall Z-2135-2021

Product

Endurant II/Endurant IIs Stent Graft System: Medtronic Endurant II Stent Graft System REF ETUF3214C102EE, ETCF3636C49EE, ETBF3216C166EE, and ETUF3614C102E. Used to treat infrarenal abdominal aortic or aortoiliac aneurysms using an endovascular approach.

Reason for recall

During stent graft deployment, the radiopaque (RO) marker bond detached from the distal end of the graft cover.

Distribution

U.S.: GA, MA, MD, NY, SC, TX, WA, and WV O.U.S.: Argentina, Australia, Germany, Greece, Israel, Italy, Netherlands, Poland, South Africa, Spain, Switzerland and United Kingdom.

Key facts

Status

Ongoing

Initiation date

2021-06-07

Report date

2021-08-04

Voluntary/Mandated

Voluntary: Firm initiated

Location

Santa Rosa, CA, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-2135-2021